Stock Fundamentals

Company Information

Company Name
Savara Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US8051111016
CIK: 0001160308
CUSIP: 00764X103
Currency: USD
Full Time Employees: 70
Phone: 512 614 1848
Fiscal Year End: December
IPO Date: Jun 01, 2017
Description:

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Address:

1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047

Directors & Officers

Name Title Year Born
Mr. Matthew Pauls J.D., M.B.A. Chairman & CEO 1971
Mr. David L. Lowrance CPA Chief Financial & Administrative Officer and Secretary 1968
Mr. Robert Matthew Lutz M.B.A. Chief Operating Officer 1969
Dr. Yasmine Wasfi M.D., Ph.D. Chief Medical Officer NA
Ms. Kate McCabe J.D. Chief Legal Officer 1986
Ms. Anne Erickson Chief Business & Corporate Affairs Officer 1972
Brian Maurer Head of Clinical Operations NA
Mr. Charles LaPree Executive VP & Head of Global Regulatory Affairs NA
Dr. Brian Robinson M.D. Executive Vice President of Global Medical Affairs NA
Dr. Siddharth J. Advant Ph.D. Executive Vice President of Global Technical Operations NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 20, 2025 Richard J Hawkins N/A Purchase 48.23K $2.04 $98.38K
May 29, 2025 Joseph S Mccracken N/A Purchase 10.00K $2.08 $20.80K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
NEA Management Company, LLC 24.47M Mar 31, 2026 11.94% $7.60 0.00%
Bain Capital Life Sciences Investors, LLC 17.60M Mar 31, 2026 8.59% $8.67 0.00%
VR Adviser, LLC 13.74M Mar 31, 2026 6.71% $2.80 0.00%
Deerfield Management Co 13.57M Mar 31, 2026 6.62% $0.87 0.00%
TCG Crossover Management, LLC 12.36M Mar 31, 2026 6.03% $1.93 0.00%
BlackRock Inc 11.29M Mar 31, 2026 5.51% $0.00 1.75%
Vanguard Group Inc 10.04M Dec 31, 2025 4.90% $0.00 20.79%
Frazier Life Sciences Management, L.P. 9.72M Mar 31, 2026 4.74% $1.37 -1.43%
Polar Capital Holdings PLC 9.54M Mar 31, 2026 4.66% $0.19 14.88%
Vanguard Capital Management, LLC 7.78M Mar 31, 2026 3.80% $0.00 0.00%
Nantahala Capital Management, LLC 7.34M Mar 31, 2026 3.58% $1.48 0.00%
State Street Corp 6.71M Mar 31, 2026 3.27% $0.00 54.80%
RTW INVESTMENTS, LLC 5.95M Mar 31, 2026 2.90% $0.32 0.00%
Marshall Wace Asset Management Ltd 4.51M Mar 31, 2026 2.20% $0.02 -1.00%
Woodline Partners LP 4.25M Mar 31, 2026 2.07% $0.09 0.01%
Geode Capital Management, LLC 3.59M Mar 31, 2026 1.75% $0.00 5.17%
Spruce Street Capital LP 3.38M Mar 31, 2026 1.65% $4.44 40.32%
Emerald Advisers, LLC 3.37M Mar 31, 2026 1.65% $0.58 -3.55%
Rosalind Advisors, Inc. 3.20M Mar 31, 2026 1.56% $7.03 -5.88%
Wellington Management Company LLP 2.71M Mar 31, 2026 1.32% $0.00 1.34%

Shares Statistics

Shares Outstanding: 204.93M
Shares Float: 130.08M
% Insiders: 257.50%
% Institutions: 10,425.10%
Short % Float: 17.23%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Polar Capital Healthcare Opports Inc 8.19M 4.00% ▲ 0.00% Apr 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 6.07M 2.96% ▲ 0.00% Apr 30, 2026
3 State Street® SPDR® S&P® Biotech ETF 3.89M 1.90% ▼ 0.62% May 31, 2026
4 iShares Russell 2000 ETF 3.52M 1.72% ▲ 0.93% May 29, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 1.53M 0.75% ▲ 1.49% Apr 30, 2026
6 Fidelity Small Cap Index 1.44M 0.70% ▲ 3.71% Mar 31, 2026
7 Polar Capital Glb Healthcare Ord 1.35M 0.66% ▲ 0.00% Apr 30, 2026
8 iShares Russell 2000 Growth ETF 1.19M 0.58% ▼ 0.65% May 29, 2026
9 UTM IM GBP AXA Framlington Biotech 1.01M 0.49% ▲ 0.00% Apr 30, 2026
10 Principal SmallCap Growth I Instl 927.79K 0.45% ▼ 0.14% Apr 30, 2026

Valuation Metrics

Enterprise Value: $906.28M
Trailing P/E: 0.00
Forward P/E: 0.41

Financial Highlights

Market Cap: $1.08B
EBITDA: $-133.17M
PEG Ratio: $0.00
Book Value: $0.69
Earnings/Share: $-0.56
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -40.53%
ROE (TTM): -79.96%
Revenue (TTM): $1.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 11.85x 0.15x 0.20x N/A -0.25x
2024-12-31 13.73x 0.16x 0.19x N/A -0.26x
2023-12-31 15.66x 0.19x 0.21x N/A -0.45x
2022-12-31 21.98x 0.24x 0.23x -441.35x -0.69x
2021-12-31 11.26x 0.18x 0.18x -18.18x -0.64x
2020-12-31 10.41x 0.39x 0.34x -33.27x -0.55x
2019-12-31 11.40x 0.25x 0.25x -1,128.93x -0.51x
2018-12-31 15.63x 0.23x 1.00x -6,367.73x -0.35x
2017-12-31 16.27x 0.13x 0.25x -25.80x -0.48x
2016-12-31 4.23x -0.08x 2.24x -23.39x -0.26x
2015-12-31 1.82x 0.62x 0.56x -65.30x -0.38x
2014-12-31 6.92x 0.00x 0.17x N/A 0.00x
2013-12-31 9.42x 0.00x 0.13x N/A 0.00x
2012-12-31 14.46x 0.00x 0.11x N/A 0.00x
2011-12-31 20.54x 0.00x 0.08x -1,216.80x 0.00x
2010-12-31 15.77x 0.00x 0.06x -5,242.29x 0.00x
2009-12-31 3.81x 0.00x 0.26x N/A 0.00x
2008-12-31 2.22x 0.00x 0.44x N/A 0.00x
2007-12-31 9.78x 0.00x 0.10x N/A 0.00x
2006-12-31 1.60x 0.00x 0.62x N/A 0.00x
2005-12-31 0.73x 0.00x 1.33x N/A 0.00x
2004-12-31 10.89x 0.00x 0.09x -4,909.16x 0.00x
2003-12-31 26.10x 0.00x 0.04x -1,690.88x 0.00x
2002-12-31 0.11x -0.23x 7.54x -39.09x -0.11x
2001-12-31 0.25x -0.09x 3.30x -886.65x 0.02x
2000-12-31 5.83x 0.00x 0.02x -158.25x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SVRA.US!